Evaluating depression among patients with cancer

Area of Science:

• Oncology
• Psychiatry
• Psychosocial Oncology

Background:

• Cancer diagnosis and treatment significantly contribute to psychiatric morbidity in patients.
• Major depression affects approximately 25% of cancer patients, with many more experiencing depressive symptoms.
• Fewer than half of cancer patients with depressive symptoms receive treatment, despite its impact on quality of life.

Purpose of the Study:

• To discuss the incidence of major depression in cancer patients.
• To provide guidelines for the diagnosis and detection of major depression.
• To describe effective cognitive and medical interventions for depression and suicide risk assessment.

Main Methods:

• Review of the incidence of major depression in cancer patients.
• Discussion of diagnostic guidelines and myth correction.
• Description of cognitive strategies and medical treatments for depression.
• Evaluation of suicide risk detection and assessment.

Main Results:

• Major depression and depressive symptoms are common in cancer patients, often undertreated.
• Alleviating depression improves quality of life and treatment compliance.
• Untreated depression is linked to lower life expectancy, increased suicide risk, and cardiac disease.

Conclusions:

• Psychiatric morbidity, including major depression, is a significant and treatable aspect of cancer care.
• Proficient psychosocial assessment by clinicians is vital for early detection and management.
• Effective interventions, including cognitive strategies and medical treatment, can improve patient outcomes and reduce suicide risk.